Reach Therapeutics Inc is categorized under Research and Development Laboratories in Wayne, PA and active since 2009.
Reach Therapeutics Inc was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Kenneth R Korzekwa at the company’s single location by writing to 216 Midland Avenue, Wayne, Pennsylvania PA 19087 or by phoning (571) 830-6501. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Reach Therapeutics Inc |
| Contact Person: | Kenneth R Korzekwa |
| Address: | 216 Midland Avenue, Wayne, Pennsylvania 19087 |
| Phone Number: | (571) 830-6501 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Reach Therapeutics Inc was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Kenneth R Korzekwa for inquiries that concern Reach Therapeutics Inc by calling the company number (571) 830-6501, as your correspondence is most welcome. Additionally, the physical location of the single location of Reach Therapeutics Inc can be found at the coordinates 40.042299,-75.381606 as well as the street address 216 Midland Avenue in Wayne, Pennsylvania 19087.
For its online presence, you may visit Reach Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.